IRIS
CILIBERTO, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.047
AS - Asia 6.952
EU - Europa 2.286
SA - Sud America 1.961
AF - Africa 142
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 20
Totale 22.433
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.687
SG - Singapore 3.152
CN - Cina 1.631
BR - Brasile 1.554
IT - Italia 923
VN - Vietnam 820
IN - India 707
SE - Svezia 420
GB - Regno Unito 386
CA - Canada 238
DE - Germania 175
HK - Hong Kong 169
AR - Argentina 161
BD - Bangladesh 117
MX - Messico 77
EC - Ecuador 71
ID - Indonesia 67
ZA - Sudafrica 53
IQ - Iraq 51
FI - Finlandia 47
NL - Olanda 46
JP - Giappone 45
RU - Federazione Russa 45
CO - Colombia 42
CL - Cile 39
UA - Ucraina 37
PL - Polonia 33
PY - Paraguay 33
ES - Italia 29
VE - Venezuela 29
MA - Marocco 26
TR - Turchia 24
SA - Arabia Saudita 23
RO - Romania 22
AU - Australia 18
FR - Francia 17
PK - Pakistan 17
UZ - Uzbekistan 17
KE - Kenya 16
PE - Perù 16
AE - Emirati Arabi Uniti 14
IR - Iran 14
CZ - Repubblica Ceca 13
EG - Egitto 13
EU - Europa 12
IE - Irlanda 12
UY - Uruguay 11
JO - Giordania 10
LT - Lituania 10
JM - Giamaica 9
AL - Albania 8
AT - Austria 8
DZ - Algeria 8
GR - Grecia 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
CH - Svizzera 7
NP - Nepal 7
BG - Bulgaria 6
HN - Honduras 6
IL - Israele 6
NZ - Nuova Zelanda 6
SN - Senegal 6
BO - Bolivia 5
GT - Guatemala 5
KZ - Kazakistan 5
MY - Malesia 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
BY - Bielorussia 4
CY - Cipro 4
EE - Estonia 4
PS - Palestinian Territory 4
BE - Belgio 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
KR - Corea 3
LB - Libano 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DK - Danimarca 2
HU - Ungheria 2
KG - Kirghizistan 2
MK - Macedonia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
Totale 22.409
Salva come PNG Salva come JPEG
Città #
San Jose 2.047
Chandler 1.195
Dallas 1.048
Ashburn 835
Singapore 811
Santa Clara 632
Hefei 581
Bengaluru 579
Milan 522
Princeton 499
Lawrence 495
Chicago 339
London 302
Ho Chi Minh City 298
Wilmington 295
Beijing 209
Hanoi 169
Ottawa 166
Hong Kong 164
Des Moines 154
Boardman 136
São Paulo 134
Munich 123
Los Angeles 87
New York 71
Shanghai 63
Rome 55
Guangzhou 47
Council Bluffs 45
Pune 43
Norwalk 42
Rio de Janeiro 40
Haiphong 37
Turku 36
The Dalles 35
Tokyo 35
Brooklyn 34
Catanzaro 34
Brasília 33
Da Nang 30
San Francisco 30
Porto Alegre 27
Belo Horizonte 26
Boston 26
Curitiba 26
Columbus 25
Guayaquil 25
Warsaw 25
Campinas 24
Montreal 23
Naples 23
Redmond 23
Wuhan 23
Baghdad 22
Hải Dương 22
Johannesburg 22
Mexico City 22
Quito 22
Redwood City 22
Atlanta 20
Biên Hòa 20
Ninh Bình 20
Stockholm 20
Asunción 19
Buenos Aires 19
Dhaka 19
Amsterdam 18
Chennai 18
Thái Bình 18
Salvador 17
Shenzhen 17
Assago 16
Charlotte 16
Falls Church 15
Seattle 15
Tashkent 15
Guarulhos 14
Jakarta 14
Manaus 14
Nairobi 14
Phoenix 14
Thái Nguyên 14
Washington 14
Bắc Ninh 13
Can Tho 13
Santo André 13
Toronto 13
Cape Town 12
Orem 12
Wuxi 12
Ann Arbor 11
Ha Long 11
Helsinki 11
Maceió 11
Manchester 11
Rui'an 11
Bauru 10
Jinan 10
Petrópolis 10
Sorocaba 10
Totale 13.552
Salva come PNG Salva come JPEG
Nome #
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2 483
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study 98
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 84
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli 82
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 81
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin 78
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 75
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 75
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro 74
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter 74
A novel minigene scaffold for therapeutic cancer vaccines 73
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 73
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines 72
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 71
T-CELL PEPTIDE EPITOPES FROM CARCINOEMBRYONIC ANTIGEN, IMMUNOGENIC ANALOGS, AND USES THEREOF 70
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) 69
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice 69
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library 69
A prokaryotic tRNA Tyr gene,inactive in Xenpous Laevis oocytes, is activated by recombination with an eukaryotic tRNA Pro gene 69
Monitoring of melanoma clinical progression by circulating NK and T cells immunoprofiling: a potential role for CCR7 in metastatic spread 67
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand 67
RHESUS EPITHELIAL CELL ADHESION MOLECULE, NUCLEIC ACID ENCODING THE SAME, AND USES THEREOF 66
Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion 66
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses 65
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 65
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 64
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 64
Adenovirus-mediated gene transfer of a human IL-6 antagonist 64
Analysis of T and Natural Killer cells immune response in Ipilimumab treated 64
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 63
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 63
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope 61
Cancer stem cells and the slow cycling phenotype: How to cut the gordian knot driving resistance to therapy in melanoma 61
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 60
CHIMERIC BIOMARKER FOR THE EARLY DIAGNOSIS AND IMMUNOTHERAPY OF CANCER 59
A federated learning system for precision oncology in Europe: DigiONE 58
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 58
PREPARATION OF RECOMBINANT ADENOVIRUS CARRYING A REP GENE OF ADENO-ASSOCIATED VIRUS 58
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 57
Phenotype characterization of human melanoma cells resistant to dabrafenib 57
Inhibition of Stearoyl-Coa desaturase 1 (SCD1) enzymatic activity reverts BRAFi and MEKi-induced selection of cancer stem cells in BRAF-mutated malignant melanoma 57
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells 57
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? 57
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 56
The molecular design of human IL-6 receptor antagonists 56
PROGRESS AND PROSPECTS: TRANSCRIPTION REGULATORY SYSTEMS 56
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system 56
MicroRNAs regulate resistance to target therapy in melanoma 56
Liver failure and defective hepatocyte regeneration in Interleukin-6 deficient mice 56
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 56
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial 56
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 56
The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape 56
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 55
Monovalent phage display of human Interleukin (hIL)-6: selection superbinder variants for a complex molecular repertoire in hIL-6 D-Helix 55
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 55
miR-579-3p controls melanoma progression and resistance to target therapy 55
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 55
HORMONE-DEPENDENT FORMS OF THE ADENO-ASSOCIATED VIRUS, REP PROTEINS, DNA SEQUENCES CODING FOR THEM, VECTORS CONTAINING THEM, AND REGULATORY METHODS OF THEIR INTRACELLULAR ACTIVITY 55
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 55
WT1 CpG islands methylation in human lung cancer: a pilot study 55
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study 54
B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis 54
Intratumor RNA interference of cell cycle genes slows down tumor progression 54
Liver specific expression of cloned human genes 54
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 54
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients 53
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas 53
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 53
Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells 52
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain 52
IMMUNOTHERAPY AGAINST ERBB-3 RECEPTOR 52
INTERLEUKIN-6 (IL-6) ANTAGONISTS 52
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 52
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin 51
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas 51
DNA sequence of a pseudogene for human C-reactive protein 51
Liver-Specific –Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis 51
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016 51
Regulation of C-reactive protein, haptoglobin and hemopexin gene expression 51
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli December 2nd-4th 2012" 51
Interleukin-6 an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells 51
The reciprocal interplay between miR-579-3p and MITF controls melanoma proliferation and resistance to target therapy 51
RECOMBINANT VECTORS DERIVED FROM ADENO-ASSOCIATED VIRUS SUITABLE FOR GENE THERAPY 51
Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism 51
T-cell agonists in cancer immunotherapy 51
Apoptotic cell death in disease-Current understanding of the NCCD 2023 51
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions 50
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 50
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 50
CARCINOEMBRYONIC ANTIGEN FUSIONS PROTEINS AND USES THEREOF 50
Involvement of the Arg179 in the active site of human IL-6 50
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 50
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 49
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy 49
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: a model for stunted growth in children with chronic inflammation 49
CD8+ T CELL TOLERANCE CAN BE BROKEN BY AN ADENOVIRUS VACCINE WHILE CD4+ T CELL TOLERANCE IS BROKEN BY ADDITIONAL CO-ADMINISTRATION OF A TOLL-LIKE RECEPTOR LIGAND 49
Enhanced inflammatory response to coronary angioplasty in patients with unstable angina 49
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 49
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop 49
Totale 6.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 244.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 244.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/20221.332 20 5 9 316 114 27 60 287 119 153 211 11
2022/20233.544 1.002 62 32 348 446 333 1 259 605 201 212 43
2023/20241.420 349 215 129 79 63 380 49 22 16 24 43 51
2024/20254.729 788 408 184 150 173 601 76 197 702 255 303 892
2025/202611.219 446 1.433 1.553 2.313 992 304 1.360 562 1.447 550 225 34
Totale 22.757